Churchill Management’s iBio IBIO Stock Holding History

Churchill Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-4	Closed	-$8K	–	181
2014 Q2	$8K	Buy	+4	New	+$8.65K	﹤0.01%	179

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GHA

GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Churchill Management's IBIO Position: Q3 2014 in Review

Churchill Management sold out of iBio (IBIO) in Q3 2014, closing a stake of 4 shares — an estimated $8K sold.

Churchill Management first reported a position in IBIO in Q2 2014 and held it in 1 quarter. The position peaked at $8K in Q2 2014. 9 funds tracked by Wall St. Rank hold IBIO as of Q3 2014.

Churchill Management reported no remaining iBio position as of Q3 2014 after selling out during the quarter.
Churchill Management sold 4 iBio shares in Q3 2014, an estimated $8K.
Churchill Management first reported a position in iBio in Q2 2014 and held it in 1 quarter.
Churchill Management's iBio position peaked at $8K in Q2 2014.
9 funds tracked by Wall St. Rank held iBio as of Q3 2014.

Based on Churchill Management's 13F filing for Q3 2014, filed 7 Oct 2014.